Ignite Creation Date:
2025-12-25 @ 12:05 AM
Ignite Modification Date:
2025-12-25 @ 10:04 PM
Study NCT ID:
NCT04992858
Status:
UNKNOWN
Last Update Posted:
2022-10-27
First Post:
2021-07-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Ningetinib in Advanced NSCLC Skipping Mutations With MET Exon 14 Skipping Mutations
Sponsor:
Sunshine Lake Pharma Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CT053-NSCLC-201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None